Sensapharm Ltd is a leading company
in small molecule analysis for the
healthcare technology sector.
Sensapharm offers state of the art small molecule identification
and quantitation primarily based upon Mass Spectrometry.
The company has substantial expertise in biomarker discovery, assay development and perhaps most
importantly, in biomarker validation. We are please to
discuss with you validated metabolomics.
We are also a world leading supplier of reference
standards and services for the anti-malarial market. This
includes reference standard material for 9-epi artemisinin and artemisitene, the key impurities in artemsinin production.
Our new work in the area of chemical profiling (sometimes
referred to as chemical fingerprinting) is particularly exciting and has the potential for application to several expanding markets, including product tracing and authentication. We use advanced mass spectrometry analyses together with sophisticated chemometrics (e.g. PCA) to identify diagnostic small molecule patterns.
© SensaPharm Ltd
The Durham Genome Centre,
UK, DH7 0EX
Tel: +44 (0) 191 543 9411 | Fax: +44 (0) 871 231 1282 |
Registered in England No. 05064784, VAT No. (GB) 847252808
Validated & non validated assays
Laboratory & field testing systems
Artemisinin and related molecule stability studies
Full Pharmacopoeal analysis
Analysis of counterfeit and substandard anti-malarial drugs
ACT and monotherapy tracing
Method development and sample processing using a range of state of the art analytical techniques.
Chemical Profiling and chemometrics
Food, drink, neutraceutical and pharmaceutical analysis
Validation of identity, origin and authenticity of plant materials and many other products
Small molecule biomarkers: